We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

GAO Slams FDA For Lax Monitoring Of Foreign Drugs

Law360 (November 1, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration has failed to tighten up and improve its safety oversight of the foreign drugs entering the country, suggesting a gaping hole in the agency's security methods, according to the Government Accountability Office.

On Thursday, the GAO presented its findings to Congress, warning lawmakers that the FDA had done little to address the safety concerns first raised by the watchdog nine years ago.

“FDA’s effectiveness in managing the foreign drug inspection program continues to be hindered by weaknesses in its databases,”...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.